Loading...

The current price of MOLN is 4.325 USD — it has increased 0 % in the last trading day.
Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
Wall Street analysts forecast MOLN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MOLN is 8.33 USD with a low forecast of 4.00 USD and a high forecast of 12.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Molecular Partners AG revenue for the last quarter amounts to 0.00 USD, decreased -100.00 % YoY.
Molecular Partners AG. EPS for the last quarter amounts to -0.33 USD, decreased -32.65 % YoY.
Molecular Partners AG (MOLN) has 159 emplpoyees as of December 15 2025.
Today MOLN has the market capitalization of 161.75M USD.